27 related articles for article (PubMed ID: 38456605)
1. ABCC2 brush-border expression predicts outcome in papillary renal cell carcinoma: a multi-institutional study of 254 cases.
Castillo VF; Masoomian M; Trpkov K; Downes M; Brimo F; van der Kwast T; Yousef GM; Zakhary A; Rotondo F; Saad G; Nguyen VN; Kidanewold W; Streutker C; Rowsell C; Hamdani M; Saleeb RM
Histopathology; 2023 Dec; 83(6):949-958. PubMed ID: 37680023
[TBL] [Abstract][Full Text] [Related]
2. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C
Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
[TBL] [Abstract][Full Text] [Related]
3. Papillary renal neoplasm with reverse polarity-a comparative study with CCPRCC, OPRCC, and PRCC1.
Wang T; Ding X; Huang X; Ye J; Li H; Cao S; Gao Y; Ma X; Huang Q; Wang B
Hum Pathol; 2022 Nov; 129():60-70. PubMed ID: 35977593
[TBL] [Abstract][Full Text] [Related]
4. Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity.
Kiyozawa D; Kohashi K; Takamatsu D; Yamamoto T; Eto M; Iwasaki T; Motoshita J; Shimokama T; Kinjo M; Oshiro Y; Yonemasu H; Oda Y
Hum Pathol; 2021 Jun; 112():48-58. PubMed ID: 33811832
[TBL] [Abstract][Full Text] [Related]
5. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract][Full Text] [Related]
6. Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma.
Castillo VF; Trpkov K; Van der Kwast T; Rotondo F; Hamdani M; Saleeb R
Pathol Int; 2024 Apr; 74(4):222-226. PubMed ID: 38456605
[TBL] [Abstract][Full Text] [Related]
7. Papillary Renal Neoplasm With Reverse Polarity: A Clinical, Pathologic, and Molecular Study of 8 Renal Tumors From a Single Institution.
Nova-Camacho LM; Martin-Arruti M; Díaz IR; Panizo-Santos Á
Arch Pathol Lab Med; 2023 Jun; 147(6):692-700. PubMed ID: 36170616
[TBL] [Abstract][Full Text] [Related]
8. Papillary renal cell neoplasm with reverse polarity: A new subtype of renal tumour with favorable prognosis.
Conde-Ferreirós M; Domínguez-de Dios J; Juaneda-Magdalena L; Bellas-Pereira A; San Miguel Fraile MP; Peteiro Cancelo MÁ; Gómez-de María C; Álvarez Sarria M; Betancor Santos MÁ; González-Carreró J; Ortiz-Rey JA
Actas Urol Esp (Engl Ed); 2022 Dec; 46(10):600-605. PubMed ID: 36216763
[TBL] [Abstract][Full Text] [Related]
9. Papillary Renal Neoplasm With Reverse Polarity Is Often Cystic: Report of 7 Cases and Review of 93 Cases in the Literature.
Wei S; Kutikov A; Patchefsky AS; Flieder DB; Talarchek JN; Al-Saleem T; Dulaimi E; Uzzo RG; Testa JR; Pei J
Am J Surg Pathol; 2022 Mar; 46(3):336-343. PubMed ID: 34352808
[TBL] [Abstract][Full Text] [Related]
10. Ipsilateral synchronous papillary renal neoplasm with reverse polarity and urothelial carcinoma in a renal transplant recipient: a rare case report with molecular analysis and literature review.
Li D; Liu F; Chen Y; Li P; Liu Y; Pang Y
Diagn Pathol; 2023 Nov; 18(1):120. PubMed ID: 37924117
[TBL] [Abstract][Full Text] [Related]
11. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
Lobo J; Ohashi R; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tickoo SK; Tsuzuki T; Turajlic S; Zhou M; Srigley JR; Moch H
Histopathology; 2022 Oct; 81(4):426-438. PubMed ID: 35596618
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic approach to eosinophilic renal neoplasms.
Kryvenko ON; Jorda M; Argani P; Epstein JI
Arch Pathol Lab Med; 2014 Nov; 138(11):1531-41. PubMed ID: 25357116
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]